Neurofibromatosis type 1 (NF1) in childhood and adolescence. Manifestation and implications for diagnostics and treatment;Neurofibromatose typ 1 (NF1) im kindes- und jugendalter. Merkmalsausprägung, diagnostik- und therapieoptionen

Monatsschrift fur Kinderheilkunde

Volumn 153, Issue 7, 2005, Pages 664-671

  Seidel, J ^a   Mentzel, H J ^a   Eichhorn, A ^a   Casten, A ^a   Kauf, E ^a   Herrmann, J ^a   Zintl, F ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Age dependent characteristics; Diagnostics; Neurofibromatosis type 1; NF1; Treatment

Indexed keywords

ADOLESCENT; AUTOSOMAL DOMINANT INHERITANCE; CAFE AU LAIT SPOT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; MACROCEPHALY; MENTAL DEVELOPMENT; NEUROECTODERM TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SKELETON MALFORMATION;

EID: 23844499960     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-005-1156-8     Document Type: Review

References (30)

1. Barbaric D, Stevens M, Dalla-Pozza L (2003) Neurofibromatosis type 1 and multiple primary malignancies. Med Pediatr Oncol 41:568-569
2. Billingsley RL, Slopis JM, Swank PR et al. (2003) Cortical morphology associated with language function in neurofibromatosis, type I. Brain Lang 85:125-139
3. Carney BT, Daniels CL (2002) A retrospective review of congenital pseudarthrosis of the tibia. Iowa Orthop J 22:57-60
4. Cnossen MH, Moons KG, Garssen MP et al. (1998) Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children
5. Cunha KS, Barboza EP, Da Fonseca EC (2003) Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1. J Clin Pathol 56:758-763
6. Curless RG (2000) Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 55:1067-1068
7. Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17:548-554
8. Goldberg Y, Dibbern K, Klein J et al. (1996) Neurofibromatosis type 1 - an update and review for the primary pediatrician. Clin Pediatr (Phila) 35:545-561
9. Gupta A, Cohen BH, Ruggieri P et al. (2003) Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology 60:130-132
10. Gutmann DH, James CD, Poyhonen M et al. (2003) Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology 61:1397-1400
11. Huson SM, Compston DA, Clark P et al. (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704-711
12. Huson SM, Harper PS, Compston DA (1988) Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111(Pt 6):1355-1381
13. King A, Listernick R, Charrow J et al. (2003) Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet 122A:95-99
14. Korones DN, Padowski J, Factor BA et al. (2003) Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? J Neurooncol 5:116-120
15. Lapid-Gortzak R, Lapid O, Monos T et al. (2000) CO2-laser in the removal of a plexiform neurofibroma from the eyelid. Ophthalmic Surg Lasers 31:432-434
16. Lasker AG, Denckla MB, Zee DS (2003) Ocular motor behavior of children with neurofibromatosis 1. J Child Neurol 18:348-355
17. Leung EW, Vanek W, Abdelhaleem M et al. (2003) The evolution of juvenile myelomonocytic leukemia in a female patient with paternally inherited neurofibromatosis type 1. J Pediatr Hematol Oncol 25:145-147
18. Nichols JC, Amato JE, Chung SM (2003) Characteristics of Lisch nodules in patients with neurofibromatosis type 1. J Pediatr Ophthalmol Strabismus 40:293-296
19. NIH (1987) Neurofibromatosis. National Institutes of Health. NIH Consens Statement 1987 July 13-15, 6:1-19
20. North K, Hyman S, Barton B (2002) Cognitive deficits in neurofibromatosis 1. J Child Neurol 17:605-612
21. Obringer AC, Meadows AT, Zackai EH (1989) The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. AmJ Dis Child 143:717-719
22. Okazak M, Yoshimura K, Suzuki Y et al. (2003) The mechanism of epidermal hyperpigmentation in cafe-au-lait macules of neurofibromatosis type 1 (von Recklinghausen's disease) may be associated with dermal fibroblast-derived stem cell factor and hepatocyte growth factor. Br J Dermatol 148:689-697
23. Packer RJ, Rosser T (2002) Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. J Child Neurol 17:638-641
24. Prinzie R Descheemaeker MJ, Vogels A et al. (2003) Personality profiles of children and adolescents with neurofibromatosis type 1. Am J Med Genet 118A:1-7
25. Riccardi VM (1992) Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 22:66-107
26. Rosser T, Packer RJ (2002) Neurofibromas in children with neurofibromatosis 1. J Child Neurol 17:585-591
27. Stoll C (2002) Difficulties in the diagnosis of neurofibomatosis-1 in children. Am J Med Genet 112:422-426
28. Virdis R, Street ME, Bandello MA et al. (2003) Growth and pubertal disorders in neurofibromatosis type 1. J Pediatr Endocrinol Metab 16 [Suppl 2]:289-292
29. Vivarelli R, Grosso S, Calabrese F et al. (2003) Epilepsy in neurofibromatosis 1. J Child Neurol 18:338-342
30. Young H, Hyman S, North K (2002) Neurofibromatosis 1: clinical review and exceptions to the rules. J Child Neurol 17:613-621